Physician Awareness of FDA’s Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic

Key Points

• Increased physician awareness of FDA changes likely influenced prescribing behaviors during COVID-19.
• Among the providers surveyed, over 70% noted shifts in laboratory testing requirements for prescriptions.
• Assessment of prescribing practices amidst the COVID-19 pandemic revealed significant deviations from prior standards.
• Implications of altered REMS regulations highlight the need for continued monitoring of clinical practices.